Courtney Schermerhorn, a high school U.S. history teacher in Texas, has spent 25 years in the classroom — long enough, she ...
A new survey conducted by the EdWeek Research Center suggests that the amount of out-of-school coursework assigned to students has fallen, in many cases because students refuse to do it, or because ...
Thanks to a new federal tax credit available in 2027, governors have begun signing up their states to access billions of additional dollars for education. More than half have already done so. Would ...
In this week’s edition of InnovationRx, we look at the FDA’s refusal to review Moderna’s flu vaccine, the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 ...
The Food and Drug Administration has refused to review Moderna’s application for an mRNA flu vaccine, the company revealed Tuesday. While the move came as a surprise to the high-profile vaccine maker, ...
Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...
FDA rejects Moderna's flu vaccine application over trial design issues Moderna shares drop as much as 12% Moderna CEO criticizes FDA's decision, cites prior agreement FDA suggests resubmission for ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Moderna is facing a regulatory ...
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has broadly rejected it, canceling millions of dollars in research projects. By ...